Ultra-High Frequency UltraSound (UHFUS) Assessment of Barrier Function in Moderate-to-Severe Atopic Dermatitis during Dupilumab Treatment

Atopic dermatitis (AD) is a chronic multifactorial inflammatory disease characterized by intense itching and inflammatory eczematous lesions. Biological disease-modifying drugs, such as dupilumab are recommended for patients with moderate-to-severe AD, refractory to systemic immunosuppressive therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Dini, Valentina, Iannone, Michela, Michelucci, Alessandra, Manzo Margiotta, Flavia, Granieri, Giammarco, Salvia, Giorgia, Oranges, Teresa, Janowska, Agata, Morganti, Riccardo, Romanelli, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487092/
https://www.ncbi.nlm.nih.gov/pubmed/37685259
http://dx.doi.org/10.3390/diagnostics13172721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487092/
https://www.ncbi.nlm.nih.gov/pubmed/37685259
http://dx.doi.org/10.3390/diagnostics13172721

Ejemplares similares